Cells mediating steroid-resistance Asthma identifiedChildren’s Hospital of Pittsburgh of UPMC researchers have claimed to identify cells that are likely to play an important role in some forms of steroid-resistant asthma, which is a complication that has the effect of making treatment more challenging.

Jay K. Kolls, MD, chief of the Division of Pediatric Pulmonary Medicine, Allergy and Immunology at Children’s Hospital and study’s senior author, remarked that the identification of T Helper Type 17 (Th17), a lineage of cells, can help scientists to develop new forms of treatment to control asthma in an effective manner. These findings are likely to benefit more than 11 million of Americans who have been diagnosed with steroid-resistant asthma.

The findings have been seen as positive steps in finding a potential new target for development of drugs that can finally lead to effective asthma control and management. It is believed that these latest findings have the potential to change the methods of treating steroid-resistant asthma in a better way.